Quintiles and Archimedes entered an agreement to co-promote clinical and commercial solutions for biopharma companies aimed at reducing the time and expense associated with developing and marketing drugs. Quintiles will incorporate Archimedes’ healthcare modeling technology, the ARCHeS Innovator, and into its existing product lifecycle solutions.

Quintiles will provide access to ARCHeS Innovator, a full-scale computer simulation model of human physiology, diseases, behaviors, interventions and healthcare systems. The model allows users to run clinically realistic virtual trials that are designed to drive better decisions in health and economic outcomes research, comparative effectiveness research, clinical trial design and portfolio management.

“ARCHeS Innovator is a tremendous tool for capturing predictive simulations from real-world research, which is vital to helping biopharma improve efficiency and productivity in the New Health,” said Rick Sax, global head of Integrated Clinical Services for Quintiles. “Turning data into insights will allow customers to make faster, better decisions across the product lifecycle and increase their probability of success.”

Mika Newton, vice president, ARCHeS and consulting business leader for Archimedes, said, “Biopharma companies are under enormous pressure to maximize the efficiency and strategic positioning of products they are developing and marketing. This partnership between Archimedes and Quintiles makes advanced simulation modeling and premier medical evidence accessible and fully integrated into customers’ clinical research and commercial activities.”